- ►bloodjournal.org [PDF] HJ Kolb, J Mittermüller, C Clemm, E Holler, … - Blood, 1990 - ncbi.nlm.nih.gov Three patients with hematologic relapse after bone marrow transplantation for
chronic myelogenous leukemia were treated with interferon alpha and transfusion
of viable donor buffy coat. All had complete hematologic and cytogenetic ... Cited by 889 - Related articles - All 3 versions
CL Sawyers… - N Engl J Med, 1999 - com.msu.edu CLINICAL FEATURES CML is a malignant clonal disorder of hemato- poietic stem
cells that results in increases in not only myeloid cells but also erythroid
cells and platelets in peripheral blood and marked myeloid hyperplasia in ... Cited by 778 - Related articles - View as HTML - BL Direct - All 10 versions
C Bonini, G Ferrari, S Verzeletti, P Servida, … - Science, 1997 - sciencemag.org American Association for the Advancement of Science, 1200 New York Avenue NW,
Washington, DC 20005. (print ISSN 0036-8075; online ISSN 1095-9203) is published
weekly, except the last week in December, by the Science Cited by 695 - Related articles - BL Direct - All 6 versions
- ►ufl.edu [PDF] JA Hansen, TA Gooley, PJ Martin, F Appelbaum … - The New England journal of medicine, 1998 - nejm.highwire.org Results The median follow-up was 5 years (range, 1.2 to 10.1). Graft failure
occurred in 5 percent of patients who could be evaluated. Acute
graft-versus-host disease of grade III or IV severity was observed in 35 ... Cited by 508 - Related articles - BL Direct - All 9 versions
- ►kku.ac.th [PDF] JM Goldman - Medicine, 2004 - Elsevier Chronic myeloid leukaemia (CML, previously termed 'chronic granulocytic
leukaemia' or 'chronic myelogenous leukaemia') appears to result from
acquisition in a single pluripotent haemopoietic stem cell of a molecular ... Cited by 475 - Related articles - BL Direct - All 30 versions
JD Neaton, H Blackburn, D Jacobs, L Kuller, … - Archives of Internal Medicine, 1992 - archinte.highwire.org Background.\p=m-\With increased efforts to lower serum cholesterol levels, it is
important to quantify associations between serum cholesterol level and causes of
death other than coronary heart disease, for which an etiologic rela- ... Cited by 438 - Related articles - All 4 versions
- ►bloodjournal.org [PDF] PJ Tutschka, EA Copelan, JP Klein - Blood, 1987 - Am Soc Hematology . Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ... Cited by 352 - Related articles - All 5 versions
- ►bloodjournal.org [PDF] RT Silver, SH Woolf, R Hehlmann, FR … - Blood, 1999 - Am Soc Hematology . Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ... Cited by 307 - Related articles - BL Direct - All 9 versions
JM Goldman, JF Apperley, L Jones, R Marcus … - New England Journal of Medicine, 1986 - content.nejm.org Between February 1981 and December 1984 we treated 52 patients with chronic
myeloid leukemia in the chronic phase and 18 patients with more advanced disease
by high-dose chemoradiotherapy followed by allogeneic bone marrow ... Cited by 278 - Related articles - All 10 versions
- ►annals.org [PDF] S Faderl, M Talpaz, Z Estrov, HM Kantarjian - Annals of internal medicine, 1999 - Am Coll Physicians Chronic myelogenous leukemia is a myeloproliferative dis- order. It is
characterized by a biphasic or triphasic clinical course in which a benign
chronic phase is followed by transformation into an accelerated and blastic ... Cited by 270 - Related articles - BL Direct - All 6 versions
